The NHS has started a nationwide campaign inviting 500,000 men who have been diagnosed with, or are living with, prostate cancer to take part in one of the world's largest prostate cancer research programmes.
The post The NHS has invited 500,000 men to join prostate cancer research appeared first on Open Access Government.
Known as Prostate Progress, the campaign is led by the charity Prostate Cancer Research and supported by the NHS DigiTrials recruitment service.
Prostate Progress hopes to improve the early detection, diagnosis and treatment of prostate cancer while helping researchers better understand the long-term impact of the disease on patients’ lives.
Eligible men will receive letters and text messages over the coming months explaining how they can register to take part.
Using patient data alongside NHS dataParticipants will be asked to complete regular questionnaires about their experiences of living with prostate cancer, including the side effects of treatment and how the disease affects their quality of life. They will also be asked to allow researchers to link their responses with their NHS health records securely.
By combining personal experiences with clinical information, researchers hope to gain a much clearer understanding of how prostate cancer develops, why some cancers become more aggressive than others, and which treatments produce the best outcomes for different patients.
The information gathered during the Prostate Progress is expected to help shape future clinical trials, improve patient care and support the development of more effective tests and treatments.
One of the key priorities of the programme is increasing participation from Black men, who face around twice the risk of developing prostate cancer compared with other groups. Around one in four Black men in the UK is expected to be diagnosed with the disease during their lifetime.
Researchers believe that improving representation within the study will help uncover why these differences exist and lead to better diagnosis, treatment and outcomes for Black men while benefiting prostate cancer care for everyone.
The need for better researchSurvival rates have improved significantly in recent decades thanks to advances in medical research and clinical trials. However, experts say there is still much to learn about the disease, particularly around identifying aggressive cancers earlier and reducing the long-term effects of treatment.
The government has also highlighted cancer research as a key priority within the National Cancer Plan for England, with a focus on expanding clinical trials and encouraging more patients to take part in research.
An initial pilot involving 5,000 participants has already shown the project’s potential, with volunteers sharing valuable insights into life after diagnosis and treatment.
Researchers hope the expansion to half a million participants will create an unprecedented research resource, allowing scientists to better connect NHS medical records with real-life patient experiences.
Prostate Progress aims to accelerate the development of new diagnostic tests, improve treatment options and ensure future generations of men receive more personalised and effective prostate cancer care.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | NHS introduces precision radiotherapy for thounsands of men with prostate cancer | 0 | 6.81 | 11-06-2026 |
| 2 | New national cancer board launched to create improvements in cancer care | 0 | 5.1 | 21-09-2026 |
| 3 | AI could transform cancer diagnosis across the NHS | 0 | 7.44 | 11-06-2026 |
| 4 | NHS rolls out pembrolizumab for women with advanced cervical cancer | 0 | 6.27 | 25-06-2026 |
| 5 | G7 renews global drive to accelerate fight against cancer | 0 | 4.19 | 18-06-2026 |
| 6 | New NHS approval creates new hope for patients with rare blood cancers | 0 | 6.31 | 17-07-2026 |
| 7 | Natural protein discovery may help predict and slow aggressive cancers | 0 | 6.86 | 07-07-2026 |
| 8 | The power of prehabiliation in cancer care | 0 | 8.08 | 19-06-2026 |
| 9 | WHO opens new pathway to child-friendly cancer medicines | 0 | 10.49 | 07-09-2026 |
| 10 | Mapping cancer’s genetic drivers: Sequencing, biomarkers and equity | 0 | 7.44 | 25-08-2026 |